For cancer patients, close is not good enough.
The Scientist
Most Recent
In discovering their shared ancestry, a distantly related animal geneticist and plant pathologist find a common thread in their work on immune receptors.
Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.
New technologies and mind-sets are required for information delivery in the age of genomics.
Drugs that target specific tumors are harbingers of a new era of genetically informed medicine.
Recent clinical trials have reignited the interest in simple anti-inflammatory drugs like aspirin for controlling the inflammation associated with cancer. The results suggest that these drugs reduced the risk of relapse as well as cancer formation ac
Can tumors—which can originate from, and often resemble, chronically inflamed tissue—be curtailed using familiar anti-inflammatory agents, without their side effects?
Preston Estep discusses the role that telomeres play in the aging process.
A snapshot of the highest-ranked articles from a 30-day period on Faculty of 1000
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
